Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 175 participants.
Also called NCT05459688
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 175 participants
- Sponsor
- Registry
-
NCT05459688
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT05459688. Allocation not applicable; no masking; primary purpose treatment. Start 2022-04-06 (actual); primary completion 2023-11-07 (actual). Results posted on 2024-12-16.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124
- Condition
- Hypertension
- Intervention (Drug)
- CIN-107
- Lead sponsor
- AstraZeneca
Record details
- Record id
cardio:ct-nct05459688- Content hash
9e9c801b9194d872b42b411104edb7b45f56a2c99a60a1fd8ee6a268ea044946